XML 50 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Schedule of worldwide net revenues The following table details AbbVie’s worldwide net revenues:
Three months ended
March 31,
(in millions)
20212020
Immunology
HumiraUnited States$3,907 $3,656 
International960 1,047 
Total$4,867 $4,703 
SkyriziUnited States$481 $266 
International93 34 
Total$574 $300 
RinvoqUnited States$245 $82 
International58 
Total$303 $86 
Hematologic Oncology
ImbruvicaUnited States$999 $966 
Collaboration revenues269 266 
Total$1,268 $1,232 
VenclextaUnited States$225 $201 
International180 116 
Total$405 $317 
Aesthetics
Botox Cosmetic (a)
United States$305 $— 
International172 — 
Total$477 $— 
Juvederm Collection (a)
United States$123 $— 
International198 — 
Total$321 $— 
Other Aesthetics (a)
United States$300 $— 
International43 — 
Total$343 $— 
Neuroscience
Botox Therapeutic (a)
United States$429 $— 
International103 — 
Total$532 $— 
Vraylar (a)
United States$346 $— 
DuodopaUnited States$25 $25 
International104 99 
Total$129 $124 
Ubrelvy (a)
United States$81 $— 
Other Neuroscience (a)
United States$156 $— 
International— 
Total$160 $— 
Three months ended
March 31,
(in millions)
20212020
Eye Care
Lumigan/Ganfort (a)
United States$66 $— 
International77 — 
Total$143 $— 
Alphagan/Combigan(a)
United States$80 $— 
International38 — 
Total$118 $— 
Restasis (a)
United States$267 $— 
International13 — 
Total$280 $— 
Other Eye Care (a)
United States$117 $— 
International159 — 
Total$276 $— 
Women's Health
Lo Loestrin (a)
United States$102 $— 
International— 
Total$104 $— 
Orilissa/OriahnnUnited States$29 $30 
International
Total$30 $31 
Other Women's Health (a)
United States
$46 $— 
International— — 
Total$46 $— 
Other Key Products
MavyretUnited States$170 $234 
International245 325 
Total$415 $559 
CreonUnited States$274 $276 
LupronUnited States$171 $195 
International42 38 
Total$213 $233 
Linzess/Constella (a)
United States$215 $— 
International— 
Total$222 $— 
SynthroidUnited States$191 $205 
All other (a)
$892 $553 
Total net revenues$13,010 $8,619 
(a) Net revenues include Allergan product revenues after the acquisition closing date of May 8, 2020.